Streptococcus pneumoniae potently induces cell death in mesothelial cells by Rashwan, R et al.
RESEARCH ARTICLE
Streptococcus pneumoniae potently induces
cell death in mesothelial cells
Rabab Rashwan1,2☯, Julius F. Varano della Vergiliana1,3☯, Sally M. Lansley1,3☯, Hui
Min Cheah1,3, Natalia Popowicz1,3,4, James C. Paton5, Grant W. Waterer6,
Tiffany Townsend7, Ian Kay7, Jeremy S. Brown8, Y. C. Gary Lee1,3,9*
1 Centre for Respiratory Health, University of Western Australia, Perth, Western Australia, Australia,
2 Department of Microbiology and Immunology, Faculty of Medicine, Minia University, Minya, Egypt,
3 School of Medicine & Pharmacology, University of Western Australia, Perth, Western Australia, Australia,
4 Department of Pharmacy, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia, 5 Research
Centre for Infectious Diseases, Department of Molecular and Cellular Biology, University of Adelaide,
Adelaide, South Australia, Australia, 6 Respiratory Department, Royal Perth Hospital, Perth, Western
Australia, Australia, 7 Dept of Microbiology & Infectious Diseases, Royal Perth Hospital, Perth, Western
Australia, Australia, 8 Centre for Inflammation and Tissue Repair, UCL Respiratory, University College
London, London, United Kingdom, 9 Dept of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth,
Western Australia, Australia
☯ These authors contributed equally to this work.
* gary.lee@uwa.edu.au
Abstract
Pleural infection/empyema is common and its incidence continues to rise. Streptococcus
pneumoniae is the commonest bacterial cause of empyema in children and among the com-
monest in adults. The mesothelium represents the first line of defense against invading
microorganisms, but mesothelial cell responses to common empyema pathogens, including
S. pneumoniae, have seldom been studied. We assessed mesothelial cell viability in vitro
following exposure to common empyema pathogens. Clinical isolates of S. pneumoniae
from 25 patients with invasive pneumococcal disease and three reference strains were
tested. All potently induced death of cultured mesothelial cells (MeT-5A) in a dose- and
time-dependent manner (>90% at 107 CFU/mL after 24 hours). No significant mesothelial
cell killing was observed when cells were co-cultured with Staphylococcus aureus, Strepto-
coccus sanguinis and Streptococcus milleri group bacteria. S. pneumoniae induced meso-
thelial cell death via secretory product(s) as cytotoxicity could be: i) reproduced using
conditioned media derived from S. pneumoniae and ii) in transwell studies when the bacteria
and mesothelial cells were separated. No excess cell death was seen when heat-killed S.
pneumoniae were used. Pneumolysin, a cytolytic S. pneumoniae toxin, induced cell death in
a time- and dose-dependent manner. S. pneumoniae lacking the pneumolysin gene (D39
ΔPLY strain) failed to kill mesothelial cells compared to wild type (D39) controls, confirming
the necessity of pneumolysin in D39-induced mesothelial cell death. However, pneumolysin
gene mutation in other S. pneumoniae strains (TIGR4, ST3 and ST23F) only partly abol-
ished their cytotoxic effects, suggesting different strains may induce cell death via different
mechanisms.
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Introduction
Bacterial pleural infection is a centuries-old disease and the global incidence continues to rise
[1]. Community-acquired pneumonia affects over 5 million people each year in the United
States [2, 3]. Of those, 20–40% will be complicated by development of a parapneumonic effu-
sion [4], which can be secondarily infected by bacteria (pleural infection) and may present
with frank pleural pus (empyema). Pleural infection is associated with a high (~20%) mortality
in adults [5].
Streptococcus pneumoniae is the commonest cause of empyema in pediatric populations [6,
7] and the second most common in adults [1]. The Streptococcus milleri group (S. anginosus, S.
intermedius and S. constellatus) is another leading cause of adult empyemas [8–10] whereas
Staphylococcus aureus is the most frequent cause of hospital-acquired empyemas [11, 12].
Mesothelial cells line the pleural cavity and are the predominant cell type in the pleura. Dur-
ing infection, the mesothelium represents the first line of defense by acting as a surface barrier
to invading pathogens [13]. Our previous animal model data showed that, following aspiration
into the lung, S. pneumoniae infects the lung parenchyma and spreads rapidly toward the lung
surface where it can disrupt the mesothelial barrier and invade the pleura to produce an empy-
ema [14].
Despite the prevalence and importance of pleural infection, few other studies have investi-
gated the effect of common bacterial pathogens (especially S. pneumoniae) on pleural mesothe-
lial cells. In this study we aimed to characterize the effect of bacterial exposure (especially S.
pneumoniae) on pleural mesothelial cell survival in vitro. The role for the secreted cytolytic
toxin pneumolysin during mesothelial cell death was also assessed using genetically modified
strains and recombinant pneumolysin.
Material and methods
Mesothelial cells
The SV40-transformed human mesothelial MeT-5A cell line was obtained from the American
Tissue Culture Collection (Manassas, VA, USA; #CRL-9994). Cells were maintained in Dul-
becco’s Modified Eagle Medium (DMEM) supplemented with 4 mM L-glutamine, 0.2 μg/ml
streptomycin, 0.2 μg/ml penicillin and 10% (v/v) fetal calf serum (FCS).
Bacterial strains and culture
Bacterial reference strains were obtained from ATCC (Table 1). S. pneumoniae clinical isolates
were cultured from patients with invasive disease and included 22 blood and 3 pleural fluid
isolates (Table 2). All clinical isolates were collected from Royal Perth Hospital (Perth, Western
Australia), except for WCH43, which was provided by Professor James Paton (University of
Adelaide, South Australia). Wild type S. pneumoniae D39, TIGR4, ST3 and ST23F strains and
their pneumolysin-negative derivatives (referred to as ΔPLY) were kindly provided by Profes-
sor Jeremy Brown (University College London, London, UK) [15, 16]. Ethics approval was
obtained from the University of Western Australia Institutional Biosafety Committee
(Approval number RA/5/1/445).
Streptococcus species were cultured in Todd Hewitt broth containing 0.5% yeast extract
(THY), while S. aureus strains were grown in Luria Bertani medium. Bacteria were stored in
broth containing 20% (v/v) glycerol at -80˚C and directly sub-cultured onto blood agar plates
for 18–24 hr at 37˚C in 5% (v/v) CO2 before use. For the ΔPLY strains, sub-culturing was per-
formed using blood agar plates supplemented with 0.2 μg/mL erythromycin. For experimenta-
tion, bacterial suspensions were prepared in 0.85% (w/v) saline to a turbidity of 0.5 McFarland
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using a Sensititre Nephelometer (Thermo Scientific; Waltham, MA, USA). Bacteria were also
subject to heat-killing at 95˚C for 1 hr. Successful heat-killing and viability of the live bacteria
was verified by plate counts. Briefly, ten-fold dilutions of each bacteria ranging from 10–1 to
10–6 colony forming units (CFU)/mL were prepared in saline, with 20 μL spotted onto blood
agar plates, and incubated overnight at 37˚C. The following day, the number of CFU per 20 μL
was counted and the CFU/mL calculated.
Preparation of S. pneumoniae conditioned media
S. pneumoniae was directly sub-cultured from blood agar plates into DMEM and incubated
overnight in a shaking incubator at 200 rpm at 37˚C. The conditioned media was filter-steril-
ized using a 0.2 μm pore size filter. For each experiment, the sterility of the conditioned media
was confirmed by plating onto blood agar.
Recombinant native pneumolysin
Recombinant native pneumolysin was purified and assessed for hemolytic activity as previously
described [17]. The preparation contained an activity of 380,000 hemolytic units per mg protein.
Bacterial infection of mesothelial cells
For all experiments, MeT-5A cells were grown to confluence in 24-well plates and deprived of
serum and antibiotics 24 hr prior to stimulation. Cells were treated with live or heat-killed bac-
teria (at 105, 106 and 107 CFU/ml in 500 μL), conditioned media or recombinant pneumolysin
for up to 24 hr. Transwell experiments were performed where MeT-5A cells were cultured in
Table 1. List of S. pneumoniae reference strains used in this study.
Strain designation Description Source
Streptococcus
pneumoniae
D39 Capsular serotype 2 [15, 16]
WCH43 Capsular serotype 4 Women’s and Children’s Hospital, North
Adelaide, Australia
TIGR4 Capsular serotype 4 ATCC1 BAA-334™
CIP 104225 Capsular serotype 3 ATCC1 6303™
Staphylococcus aureus
Seattle 1945 Clinical isolate obtained in Seattle in 1945 ATCC1 25923™
Smith Clinical isolate ATCC1 13709™
Streptococcus
anginosus
NCTC 10713 Isolated from human throat tissue ATCC1 33397™
Streptococcus
intermedius
VPI 3372A Type strain ATCC1 27335™
Streptococcus
constellatus
VPI 3810 Isolated from a patient with purulent
pleurisy
ATCC1 27823™
Streptococcus
sanguinis
DSS-10 Isolated from a patient with sub-acute
bacterial endocarditis
ATCC1 10556™
https://doi.org/10.1371/journal.pone.0201530.t001
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24-well plates and 200 μL of a S. pneumoniae suspension (2 x 107 CFU/mL) was transferred
into the upper chamber of Corning1 Transwell1 polyester membrane cell culture inserts
(6.5 mm diameter, 0.4 μm pore size; Sigma-Aldrich). The transwell design did not allow physi-
cal contact between the mesothelial cells and bacteria. Viability of the bacteria in the upper
chamber and their exclusion within the lower chamber was verified by plating onto blood agar
using aliquots of the supernatant from each chamber. At the conclusion of each experiment
the cells were analyzed for viability using flow cytometry.
Determination of cell viability
Cell viability was assessed using a LIVE/DEAD1 Fixable Dead Cell Stain kit (Invitrogen; Vic-
toria, Australia) according to the manufacturer’s instructions. Briefly, cells were harvested by
trypsinization and washed with PBS. Cells were then stained with 1:1000 diluted green fluores-
cent reactive dye for 30 min, washed with PBS and fixed in 4% (w/v) paraformaldehyde for 15
min. Following this, cells were resuspended in PBS and fluorescence detected by flow cytome-
try using a 530/30 bandpass filter. Data (each 10,000 events) were acquired and analyzed using
a BD FACSCalibur with FACSDiva version 5 software (BD Bioscience; San Jose, CA, USA).
Hemolysis assay
Cytolytic activity of the clinical isolates, reference, wild type and ΔPLY S. pneumoniae strains
was determined semi-quantitatively using an erythrocyte hemolysis assay [18]. Bacterial
Table 2. List of Streptococcus pneumoniae clinical isolates used in this study.
Strain designation Capsular serotype Source
RPH 31856 1 Pleural fluid
P11-9566884P 1 Blood culture
P12-3039379M 8 Blood culture
P12-3035869G 8 Blood culture
P11-9618385UM 8 Blood culture
P12-9552330W 6B Blood culture
P11-9608890J 6C Blood culture
P11-9624937G 10A Blood culture
RPH 31337 11A Pleural fluid
P11-9653902K 11A Blood culture
P11-9613539M 12F Blood culture
P11-9594082Q 16F Blood culture
RPH 31450 19A Pleural fluid
P11-9645796U 19A Blood culture
P11-3086723K 19A Blood culture
P11-9607769H 19A Blood culture
P11-9591891X 19A Blood culture
P11-3048281G 19A Blood culture
P11-9585892W 19A Blood culture
P11-3047887E 19A Blood culture
RPH 31018 19F Blood culture
P12-3029494R 21 Blood culture
P12-3028290U 22F Blood culture
P11-9611457G 22F Blood culture
P12-9562415S 35B Blood culture
https://doi.org/10.1371/journal.pone.0201530.t002
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suspensions were made in PBS and pelleted at 10,000 x g for 5 min. The pellet was lysed using
1% (w/v) sodium deoxycholate and stored at -20˚C until required. Protein concentrations of
the clarified lysates were determined using the DC Protein Assay kit (Bio-Rad: Hercules, CA,
USA), according to the manufacturer’s instructions. A 5% (v/v) erythrocyte suspension was
prepared from whole human blood and activated for 15 min at room temperature following
the addition of 20 mM 2-mercaptoethanol. A 100 μL aliquot of each lysate (50 μg/mL) was seri-
ally diluted in PBS and an equal volume of erythrocyte suspension was added. The samples
were incubated at 37˚C for 30 min and centrifuged at 800 x g for 5 min. The absorbance of the
supernatant at 540 nm was then measured. Erythrocytes treated with PBS alone were included
as a measure of background absorbance and used to correct absorbance values of samples
treated with lysates.
Western blot analysis
Bacterial cell lysis was performed using RIPA buffer containing 1X protease and phosphatase
inhibitor cocktail (Thermo Fisher). Lysates were kept on ice for 30 mins with vortexing every
10 mins then centrifuged at 4˚C 14,000 x g for 20 minutes before supernatants were transferred
to a clean microfuge tube and stored at -20˚C. Protein was quantified using Coomassie Plus
reagent as per manufacturer’s instructions (BioRad). Ten micrograms of protein was dena-
tured by heating at 95˚C for 5 minutes, separated on 4–12% Bis-Tris gels (Invitrogen) and
transferred onto nitrocellulose membranes using the iBlot system (Invitrogen). Membranes
were blocked for 1 hour at room temperature in 5% skim milk/TBS-T (TBS with 0.05% Tween
20). Membranes were then incubated with anti-pneumolysin (sc-80500; 1:500: Santa Cruz Bio-
technology) in TBST containing 5% skim milk powder on a roller overnight at 4˚C. After
washing a further 3 times with TBST for 5 minutes, blots were incubated with rabbit anti-
mouse HRP-conjugated secondary antibody (ab6728: 1:10,000 Abcam) for 1 hour at room
temperature. Membranes were visualized using the Pierce™ ECL Western Blotting Substrate
(Pierce) and hyperfilm ECL (GE Healthcare, UK).
Statistical analysis
Data are presented as the mean ± standard error of the mean (SEM). Student’s t test with
Bonferroni correction was used to compare differences between two treatment groups. A
p value <0.05 was considered statistically significant. Analyses were conducted using Graph-
Pad Prism 4.0 (La Jolla, CA, USA).
Results
S. pneumoniae potently induces death of pleural mesothelial cells
To investigate the effect of bacteria on pleural mesothelial cell survival, confluent MeT-5A
monolayers were co-cultured with a range of common bacterial pleural empyema pathogens.
Twenty five clinical isolates of S. pneumoniae isolated from patients with invasive pneumococ-
cal diseases were tested (Table 2), of which 23 induced significant killing of pleural mesothelial
cells (median % dead cells at 107 CFU/mL, 97%; p< 0.0001 compared to vehicle controls).
Further, when heat-killed, none of the 25 clinical isolates tested were able to induce mesothelial
cell death (Fig 1A).
In subsequent experiments 3 reference strains were used (Table 1) to explore the mecha-
nisms of S. pneumoniae-induced cell death. Following infection for 24 hr, S. pneumoniae
TIGR4, CIP 104225 and WCH43 strains potently induced death of MeT-5A cells (Fig 1B).
Mesothelial cell death was observed at all bacterial doses used and no significant difference in
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cell death was seen between doses higher than 105 CFU/mL. At 107 CFU/mL, TIGR4, CIP
104225 and WCH43 strains killed 93.7%, 99.2% and 99.9% of MeT-5A cells, respectively
(p< 0.0001 compared to vehicle control) (Fig 1B).
In subsequent experiments, a time course response to infection with the S. pneumoniae
TIGR4 strain was also determined. As shown in Fig 1C, a significant increase in cell death was
seen as early as 2 hr post-infection in cells treated with the highest bacterial dose (107 CFU/
mL). This response continued to increase for all subsequent time points measured (2, 4, 6 and
24 hr post-infection: 8.2%, 14.3%, 17.4% and 93% of total; p< 0.05 for all time points). In con-
trast, cell death was only significantly induced at the 24 hr time point in cells treated with 105
or 106 CFU/mL (p< 0.0001; Fig 1C).
Heat-killing of S. pneumoniae abolished its ability to induced mesothelial
cell death
To determine whether S. pneumoniae-induced cell death was dependent on the presence of
live bacteria, S. pneumoniae (TIGR4 strain) was heat treated prior to co-culture with mesothe-
lial cells. Compared to live bacteria, heat-killed TIGR4 failed to induce MeT-5A cell death at
Fig 1. Infection with Streptococcus pneumoniae induces death of pleural mesothelial cells. A) The effect of S. pneumoniae on mesothelial cell death was assessed using
25 clinical isolates obtained from patients with invasive pneumococcal disease. B) MeT-5A cells were treated with increasing doses of live S. pneumoniae reference
strains. C) Time course of MeT-5A cell death following S. pneumoniae TIGR4 infection was also assessed. D) Time course of MeT-5A cell death following co-culture
with S. pneumoniae TIGR4 following heat-treatment at 95˚C for 1 hr and viability determined at various time points up to 24 hr post-infection.  Denotes significantly
higher than vehicle control and heat-killed bacteria.
https://doi.org/10.1371/journal.pone.0201530.g001
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all concentrations used and at all time points measured (% dead cells 24 hr post-infection at
107 CFU/mL; live, 94%; heat-killed, 4.5%; p< 0.0001) (Fig 1D).
Infection with other empyema-causing bacterial strains did not induce
mesothelial cell death
Treatment of MeT-5A cells with S. aureus Smith strain induced a very mild dose-dependent
increase in cell death up to 11% at 107 CFU/mL (p< 0.001; Fig 2A). In contrast, S. aureus Seat-
tle 1945 strain, S. milleri bacteria and S. sanguinis had negligible effect on mesothelial cell via-
bility at all concentrations tested (Fig 2A–2C).
S. pneumoniae-induced mesothelial cell death is mediated via a secreted
bacterial product
In subsequent experiments we assessed the potential role for a secreted product in S. pneumo-
niae-induced mesothelial cell death. Cell-free conditioned media derived from S. pneumoniae
TIGR4, CIP 104225 and WCH43 strains significantly induced death of MeT-5A cells com-
pared to vehicle controls (Fig 3A; p< 0.0001). This effect was similar in potency to treatment
with live S. pneumoniae. To further explore this observation, MeT-5A cells were co-cultured
with the S. pneumoniae TIGR4 strain using Transwell1 inserts. As shown in Fig 3B, culture of
TIGR4 in the top chamber of a Transwell1 insert still resulted in death of the mesothelial cell
layer in the bottom chamber (p< 0.0001). Media obtained from the bottom well was devoid of
bacteria.
S. pneumoniae-induced mesothelial cell death is partly mediated by
pneumolysin
Pneumolysin is a potent cytolytic toxin produced by all clinically isolated S. pneumoniae
strains and represents a major virulence determinant in pneumococcal disease [19]. Given
this, the role of pneumolysin in S. pneumoniae-induced mesothelial cell death was investigated.
First, cultured mesothelial cells were treated with recombinant pneumolysin to assess for
toxin-induced lysis. As shown in Fig 4A, pneumolysin potently induced MeT-5A cell death at
1000 and 3000 ng/mL (p< 0.0001 compared to the vehicle control).
We then employed a variety of wild type and pneumolysin-negative mutant strains to verify
the importance of the toxin in this process. All parental wild type strains produced cytolytic
toxins, as assessed by an erythrocyte hemolysis assay. In contrast, none of the ΔPLY strains
Fig 2. Infection of mesothelial cells with non-S. pneumoniae bacterial strains does not potently induce cell death. A-C) MeT-5A cells were treated with increasing
doses of live S. aureus (A), S. milleri group bacteria (B) or S. sanguinis (C) and cell viability was assessed.  Denotes significantly higher than vehicle control.
https://doi.org/10.1371/journal.pone.0201530.g002
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were cytolytic, (Fig 4B). Wild type S. pneumoniae D39 potently killed the mesothelial cells, but
the D39 ΔPLY failed to induce mesothelial cell death (Fig 4C), confirming that pneumolysin
mediates the D39-induced cell killing. In contrast, TIGR4, ST3 and ST23F and their respective
ΔPLY strains were equally potent in killing mesothelial cells, suggesting these strains employed
a different mechanism (other than pneumolysin) in inducing cell death.
We extended the dose response of MeT-5A cells to D39 ΔPLY and confirmed that D39
ΔPLY failed to induce cell death even at concentrations up to 5 x 107 CFU/mL (Fig 5A). Lower
doses of TIGR4, ST3 and ST23F ΔPLY strains still induced MeT-5A cell death albeit to varying
degrees. TIGR4 ΔPLY induced MeT-5A cell death at all doses tested (Fig 5B). In contrast, no
cytotoxic effect was observed for concentrations up to 105 CFU/mL and 104 CFU/mL for ST3
and ST23F ΔPLY strains, respectively (Fig 5C and 5D). Heat-killing of TIGR4, ST3 and ST23F
ΔPLY strains abolished the cytotoxic activity of the bacteria on MeT-5A cells (Fig 6A). Further,
treatment of MeT-5A cells with conditioned media from TIGR4, ST3 and ST23F ΔPLY strains
significantly induced cell death (39.9%, 82.65% and 80.8%, respectively compared to vehicle
controls; p< 0.01 for all; Fig 6B). Conditioned media from the TIGR4 ΔPLY strain induced
cell death to a notably lesser extent than ST3 and ST23.
To determine whether a secreted product was also responsible for the mesothelial cell cyto-
toxicity observed by clinical bacterial isolates, we quantified their hemolytic activity (Fig 7A).
Fig 3. S. pneumoniae-induced mesothelial cell death is mediated by a bacterial secreted product. A) MeT-5A cells were incubated with cell-free bacteria conditioned
media. B) S. pneumoniae was loaded into the top chamber of a Transwell1 insert and viability of MeT-5A cells was determined in the bottom chamber. Cell viability
was assessed 24 hr post-treatment.  Denotes significantly higher than vehicle control.
https://doi.org/10.1371/journal.pone.0201530.g003
Fig 4. The role of pneumolysin in S. pneumoniae-induced cell death. A) MeT-5A cells were treated with a purified, recombinant preparation of pneumolysin and
viability determined 24 hr post-treatment. B) Lysates prepared from wild type S. pneumoniae strains and their pneumolysin-negative derivatives (ΔPLY) were assessed
for cytolytic activity using an erythrocyte hemolysis assay. C) MeT-5A cells were infected with wild type and ΔPLY S. pneumoniae strains and viability determined 24 hr
post-infection.  Denotes significantly higher than vehicle control.
https://doi.org/10.1371/journal.pone.0201530.g004
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Most isolates produced cytolytic proteins, albeit to varying degrees. Combined with the results
observed for the reference, wild type and ΔPLY strains, this added further support to a role for
pneumolysin in mesothelial cell killing. We therefore assessed pneumolysin protein expression
in the S. pneumoniae clinical bacterial isolates by Western blot (Fig 7B). All but one (31337) of
the S. pneumoniae clinical isolates were positive for pneumolysin expression. Pneumolysin
protein expression was also confirmed in the wild type but not the ΔPLY S. pneumoniae or S.
milleri and S. sanguinis strains (Fig 7C).
Discussion
Since first being described over 2000 years ago, pleural infection remains a major respiratory
illness [20], and its global incidence is rising [1] despite advances in antibiotics and vaccination
Fig 5. Dose response of wild type and pneumolysin-negative mutant S. pneumoniae strains on pleural mesothelial cell death. A-D) MeT-5A cells were treated with
various concentrations of D39 (A), TIGR4 (B), ST3 (C) or ST23F (D) wild type and pneumolysin mutant (ΔPLY) strains and viability determined 24 hr post-infection. 
Denotes significantly higher than vehicle control. # Denotes significant higher than ΔPLY strain.
https://doi.org/10.1371/journal.pone.0201530.g005
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[21, 22]. Our understanding of the underlying pathobiology of this disease remains limited
and although mesothelial cells are the most abundant cell type within the pleural cavity and S.
pneumoniae is one of the most common causative agents of empyema, the host/pathogen
interactions between these cells have seldom been studied.
Mesothelial cells can phagocytoze invading bacteria, release a large range of pro-inflamma-
tory cytokines to recruit immune cells to the pleural cavity and induce fibrogenic reactions
and septations/loculations to contain unwanted material within the pleural cavity. The ability
of bacteria to compromise the mesothelial barrier (by killing mesothelial cells) will aid entry
into, and subsequent bacterial proliferation within, the pleural cavity [23–25].
We showed, for the first time, that S. pneumoniae potently induced death of pleural meso-
thelial cells. These findings were validated using a large number of clinical isolates. This result
was consistent across all reference strains tested and could be reproduced in 92% of the clinical
isolates tested. Furthermore, mesothelial cell death occurred rapidly (<2 hrs) after exposure to
S. pneumoniae, suggesting damage of the mesothelial barrier may be an early event in the onset
of pleural infection. This potent cytotoxic effect on mesothelial cells was not observed follow-
ing treatment with the other strains of common empyema bacteria we tested [8–10, 26].
Using several approaches, we confirmed that mesothelial cell killing was mediated by bacte-
rial product(s) released by live S pneumoniae. The particular product(s) however appeared to
vary among different strains of S pneumoniae. In the S. pneumoniae D39 strain, the cytotoxicity
to mesothelial cells was mediated by pneumolysin and could be abolished by using S. pneumo-
niae mutant strains that lacked the pneumolysin gene (ΔPLY strains). Various common empy-
ema pathogens, including S. pneumoniae strains, vary in their degree of pleural cytotoxicity
but this study is the first to demonstrate this phenomenon towards mesothelial cells. Our data
suggests that this may be due, in part, to the employment of separate pneumolysin-dependent
and/or -independent mechanisms in order to mediate mesothelial cell death.
Pleural infection is traditionally viewed as an extension of lung parenchymal infection dur-
ing pneumonia. In our published murine model of pneumococcal empyema, inhalation of S.
pneumoniae induced histologic consolidation of the lung parenchyma and spread rapidly from
the peri-bronchial areas to infect the visceral pleural mesothelial cells and enter into the pleural
cavity. It is therefore probable that different microbes may employ alternate route(s) of entry
Fig 6. The effect of heat-killing and conditioned media derived from pneumolysin mutant S. pneumoniae strains on pleural mesothelial cell death. A) MeT-5A
cells were incubated with either live (open bars) or heat-treated (closed bars) S. pneumoniae pneumolysin mutant strains (ΔPLY). B) MeT-5A cells were treated with
conditioned media derived from S. pneumoniae ΔPLY strains. Cell viability was determined 24 hr post-treatment  Denotes significantly higher than vehicle control.
https://doi.org/10.1371/journal.pone.0201530.g006
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to the pleural cavity. S milleri, for example, is a common causative agent for empyema, but
rarely causes pneumonia. Computed tomography studies confirmed that a subgroup of empy-
ema patients had no evidence of lung parenchymal infection. Our finding of high lethality of S.
pneumoniae against mesothelial cells supports its direct invasion of the pleura through breach-
ing the visceral mesothelium via translocation [14]. Our observation may also lend support to
the hypothesis that other common microbes infect the pleura via different mechanisms. Non-
cytotoxic bacteria, including S. aureus and viridans streptococci likely employ additional viru-
lence strategies against mesothelial cells during pleura infection. These could include stimula-
tion of cytokine release [24, 27–29], induction of mesothelial permeability [24] and cellular
internalization and intracellular survival [14, 23, 30].
Pneumolysin is a cholesterol-dependent cytolysin, which forms large pores in membranes
resulting in cell lysis and invasion of S. pneumoniae into host tissues [31]. We demonstrated
that mesothelial cells are susceptible to pneumolysin-induced cell death when treated with
Fig 7. Hemolytic activity and pneumolysin expression in bacterial isolates. A) Lysates isolated from clinical S. pneumoniae isolates were assessed for cytolytic activity
using an erythrocyte hemolysis assay. Pneumolysin protein expression was assessed by Western blot in lysates obtained from B) clinical and C) wild type and ΔPLY S.
pneumoniae isolates strains and S. milleri and S. sanguinis strains.
https://doi.org/10.1371/journal.pone.0201530.g007
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pneumolysin. This was further confirmed when S. pneumoniae D39 ΔPLY failed to cause
death of mesothelial cells. This result is consistent with other studies reporting attenuated cyto-
toxicity using pneumolysin mutated D39 [32, 33]. However, three other S. pneumoniae strains
tested (TIGR4, ST3 and ST23F) were significantly less affected by pneumolysin gene mutation
(ΔPLY). These ΔPLY strains produced a significantly weaker cytotoxic effect than the wild
type strains, suggesting a role for pneumolysin-independent mechanism(s) in mesothelial cell
death. Though the precise nature of these additional mechanisms was outside the scope of our
study, this would suggest that both a capsular component/s and a secreted product (other than
pneumolysin) may be required. Our results using heat-killed bacteria and conditioned media
from the ΔPLY strains also favored the role of additional bacterial secreted product(s), rather
than direct toxicity (e.g. via internalisation of S. pneumoniae) [34]. Given the absence of hemo-
lytic activity in the ΔPLY strains, the secreted factor likely mediates cell death independent of
direct cell lysis. Recently, S. pneumoniae ClpP protease was shown to induce apoptosis of
human neuroblastoma cells [35]. Similarly, pneumococcal cell wall components released as a
result of autolysis during growth are cytotoxic to some cell types [32, 36, 37]. These mecha-
nisms warrant exploration.
There are limitations to our study. Although MeT-5A cells are considered the standard for
mesothelial cell related studies, due to the considerable challenge of isolating primary cells in
sufficient quantitites to establish reproducible in vitro models, the transformed nature of the
cells may potentially confound interpretation of results. In addition, we investigated the direct
cytotoxic effects of different bacteria on mesothelial cells in vitro, which did not incorporate
any interactions of the bacteria that may initiate or augment cytotoxicity from other immune
cells in vivo. Also, the precise impact of this lethality and any potential in therapeutic interven-
tion need to be explored in animal models and human studies in future. In addition, intra-
strain differences in S. aureus-induced cell death of peritoneal mesothelial cells [25] and a
larger number of S. aureus and S. milleri strains need to be studied to make a firm conclusion
of differences in their behavior from S. pneumoniae.
In conclusion, our results demonstrate that S pneumoniae is a potent inducer of pleural
mesothelial cell death. Pneumolysin, although necessary for some S. pneumoniae strains, is not
the sole pneumococcal mediator responsible for mesothelial cytotoxicity. Future studies are
required to elaborate the relevance of these findings in vivo.
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